Income Taxes (Details) - Schedule of Deferred Tax Assets and Liabilities - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Deferred tax assets:
Net operating loss carry forwards	$ 30,731	$ 26,768
Capitalized research and development	9,611	3,418
Stock option expense	4,464	2,477
Research and development credits	4,824	3,710
Operating lease liability	1,485	1,481
RSU expense	2,723	2,199
Other	467	408
Total deferred tax assets	54,305	40,461
Valuation allowance	(52,734)	(38,983)
Deferred tax assets, net of valuation allowance	1,571	1,478
Deferred tax liabilities:
Operating right-of-use asset	(1,430)	(1,456)
Other	(141)	(22)
Total deferred tax liabilities	(1,571)	(1,478)
Deferred tax assets, net of valuation allowance and deferred tax liabilities